These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


256 related items for PubMed ID: 34662718

  • 1. Suprachoroidal delivery of bevacizumab in rabbit in vivo eyes: Rapid distribution throughout the posterior segment.
    Sher I, Goldberg Z, Bubis E, Barak Y, Rotenstreich Y.
    Eur J Pharm Biopharm; 2021 Dec; 169():200-210. PubMed ID: 34662718
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M, Li X, Liu J, Han Y, Cheng L.
    J Control Release; 2015 Apr 10; 203():109-17. PubMed ID: 25700623
    [Abstract] [Full Text] [Related]

  • 6. A Novel Device for Suprachoroidal Drug Delivery to Retina: Evaluation in Nonhuman Primates.
    Rotenstreich Y, Sher I, Lawrence M, Mangelus M, Ingerman A, Barak Y.
    Transl Vis Sci Technol; 2023 Jun 01; 12(6):3. PubMed ID: 37289173
    [Abstract] [Full Text] [Related]

  • 7. Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model.
    Abarca EM, Salmon JH, Gilger BC.
    J Ocul Pharmacol Ther; 2013 Oct 01; 29(8):715-22. PubMed ID: 23822159
    [Abstract] [Full Text] [Related]

  • 8. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection.
    Zhang Y, Bazzazi H, Lima E Silva R, Pandey NB, Green JJ, Campochiaro PA, Popel AS.
    Invest Ophthalmol Vis Sci; 2018 Oct 01; 59(12):5266-5276. PubMed ID: 30383198
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of injecting increasing volumes into the extravascular spaces of the choroid using a blunt adjustable depth injector.
    Sher I, Bubis E, Ketter-Katz H, Goldberg Z, Saeed R, Rotenstreich Y.
    Int Ophthalmol; 2020 Nov 01; 40(11):2865-2874. PubMed ID: 32617801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes.
    Seiler GS, Salmon JH, Mantuo R, Feingold S, Dayton PA, Gilger BC.
    Invest Ophthalmol Vis Sci; 2011 Jul 29; 52(8):5730-6. PubMed ID: 21685338
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.
    Tyagi P, Kadam RS, Kompella UB.
    PLoS One; 2012 Jul 29; 7(10):e48188. PubMed ID: 23118950
    [Abstract] [Full Text] [Related]

  • 15. Circumferential flow of particles in the suprachoroidal space is impeded by the posterior ciliary arteries.
    Chiang B, Kim YC, Edelhauser HF, Prausnitz MR.
    Exp Eye Res; 2016 Apr 29; 145():424-431. PubMed ID: 26976663
    [Abstract] [Full Text] [Related]

  • 16. Targeting drug delivery within the suprachoroidal space.
    Jung JH, Chae JJ, Prausnitz MR.
    Drug Discov Today; 2019 Aug 29; 24(8):1654-1659. PubMed ID: 30953867
    [Abstract] [Full Text] [Related]

  • 17. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J, Lan B, Li X, Sun S, Lu P, Cheng L.
    J Control Release; 2016 Dec 10; 243():78-85. PubMed ID: 27717742
    [Abstract] [Full Text] [Related]

  • 18. Transscleral Iontophoresis for Noninvasive Ocular Drug Delivery of Macromolecules.
    Molokhia S, Papangkorn K, Butler C, Higuchi JW, Brar B, Ambati B, Li SK, Higuchi WI.
    J Ocul Pharmacol Ther; 2020 May 10; 36(4):247-256. PubMed ID: 32155098
    [Abstract] [Full Text] [Related]

  • 19. Distribution of particles, small molecules and polymeric formulation excipients in the suprachoroidal space after microneedle injection.
    Chiang B, Venugopal N, Edelhauser HF, Prausnitz MR.
    Exp Eye Res; 2016 Dec 10; 153():101-109. PubMed ID: 27742547
    [Abstract] [Full Text] [Related]

  • 20. Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space.
    Jung JH, Kim SS, Chung H, Hejri A, Prausnitz MR.
    J Control Release; 2022 Dec 10; 352():472-484. PubMed ID: 36309098
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.